NCT01468831View on ClinicalTrials.gov

Minocycline to Treat Branch Retinal Vein Occlusion

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 28, 2012

Primary Completion Date

February 25, 2020

Study Completion Date

March 18, 2021

Conditions
Retinal Vein Occlusion
Interventions
DRUG

Minocycline

100 mg of minocycline in a pink opaque capsule

OTHER

Placebo

Pill with inactive ingredients in a pink opaque capsule

DRUG

Bevacizumab

1.25 mg bevacizumab injection

Trial Locations (2)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

Unknown

Bristol Eye Hospital, Bristol

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT01468831 - Minocycline to Treat Branch Retinal Vein Occlusion | Biotech Hunter | Biotech Hunter